Multidrug resistance (MDR): A widespread phenomenon in pharmacological therapies

A Catalano, D Iacopetta, J Ceramella, D Scumaci… - Molecules, 2022 - mdpi.com
Multidrug resistance is a leading concern in public health. It describes a complex phenotype
whose predominant feature is resistance to a wide range of structurally unrelated cytotoxic …

Melatonin receptor ligands: a pharmaco‐chemical perspective

JA Boutin, PA Witt‐Enderby, C Sotriffer… - Journal of pineal …, 2020 - Wiley Online Library
Melatonin MT1 and MT2 receptor ligands have been vigorously explored for the last 4
decades. Inspection of approximately 80 publications in the field revealed that most …

MT1 and MT2 Melatonin Receptors: Ligands, Models, Oligomers, and Therapeutic Potential

DP Zlotos, R Jockers, E Cecon, S Rivara… - Journal of medicinal …, 2014 - ACS Publications
Numerous physiological functions of the pineal gland hormone melatonin are mediated via
activation of two G-protein-coupled receptors, MT1 and MT2. The melatonergic drugs on the …

2-Aminobenzothiazole derivatives: search for new antifungal agents

A Catalano, A Carocci, I Defrenza, M Muraglia… - European Journal of …, 2013 - Elsevier
A new series of 6-substituted 2-aminobenzothiazole derivatives were synthesized and
screened in vitro as potential antimicrobials. Almost all the compounds showed antifungal …

[HTML][HTML] Evaluation of the Potential Cytoprotective Effect of Melatonin in Comparison with Vitamin E and Trolox against Cd2+-Induced Toxicity in SH-SY5Y, HCT 116 …

R Mallamaci, A Barbarossa, A Carrieri… - International Journal of …, 2024 - mdpi.com
Cadmium (Cd) toxicity poses a significant threat to cellular health, leading to oxidative stress
and cell damage. Antioxidant agents, particularly those of natural origin, have been studied …

[HTML][HTML] Chiral pyrrolidines as multipotent agents in Alzheimer and neurodegenerative diseases

A Carrieri, A Barbarossa, M de Candia… - Bioorganic & Medicinal …, 2024 - Elsevier
In pharmaceutical science and drug design the versatility of the pyrrolidine scaffold relating
to spatial arrangement, synthetic accessibility and pharmacological profile is a largely …

Melatonergic drugs in development

A Carocci, A Catalano, MS Sinicropi - … : advances and applications, 2014 - Taylor & Francis
Melatonin (N-acetyl-5-methoxytryptamine) is widely known as “the darkness hormone”. It is a
major chronobiological regulator involved in circadian phasing and sleep-wake cycle in …

In silico drug discovery of melatonin receptor ligands with therapeutic potential

GM Elisi, L Scalvini, A Lodola, A Bedini… - Expert Opinion on …, 2022 - Taylor & Francis
Introduction The neurohormone melatonin (N-acetyl-5-methoxytryptamine) regulates
circadian rhythms exerting a variety of effects in the central nervous system and in periphery …

Access to Optically Enriched α-Aryloxycarboxylic Esters via Carbene-Catalyzed Dynamic Kinetic Resolution and Transesterification

B Liu, R Song, J Xu, PK Majhi, X Yang, S Yang… - Organic …, 2020 - ACS Publications
Optically active α-aryloxycarboxylic acids and their derivatives are important functional
molecules. Disclosed here is a carbene-catalyzed dynamic kinetic resolution and …

Recent progress in the development of agonists and antagonists for melatonin receptors

DP Zlotos - Current medicinal chemistry, 2012 - ingentaconnect.com
The various physiological actions of the neurohormone melatonin are mediated mainly by
two G-protein-coupled MT1 and MT2 receptors. The melatoninergic drugs on the market …